A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

Clinical Infectious Diseases

Volumn 35, Issue 4, 2002, Pages 359-366

  Bowden, Raleigh ^a   Chandrasekar, Pranatharthi ^b   White, Mary H ^c   Li, Xin ^d   Pietrelli, Larry ^d   Gurwith, Marc ^d   Van Burik, Jo Anne ^a   Laverdiere, Michel ^g   Safrin, Sharon ^e   Wingard, John R ^f  

^a Fred Hutchinson Cancer Research Center   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d SEQUUS Pharmaceuticals   (United States)

^e InterMune   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; CAUSE OF DEATH; CHILD; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG RESPONSE; DRUG SAFETY; FEMALE; FEVER; HUMAN; HYPOXIA; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0037103116     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/341401     Document Type: Article

References (24)

1. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
2. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis: An autopsy study of 355 patients
3. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: A 9-year study
4. Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases
5. Antifungal agents used for deep-seated mycotic infections
6. Amphotericin B: 30 years of clinical experience
7. Amphotericin B revisited: Reassessment of toxicity
8. Drug-induced nephrotoxicity: Aetiology, clinical features and management
9. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation
10. Novel antifungal drug delivery: Stable amphotericin B-cholesteryl sulfate discs
11. Pharmacokinetic study of a novel amphotericin B colloidal dispersion with improved therapeutic index
12. Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion
13. Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis
14. Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis
15. Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant
16. The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses
17. Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion
18. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients
19. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis
20. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
21. NIAID Mycoses Study Group Multicenter Trial of oral itraconazole therapy for invasive aspergillosis
22. Therapeutic outcome in invasive aspergillosis
23. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
24. An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment ofinvasive aspergillosis